跳至主要内容
临床试验/NCT00861159
NCT00861159撤回不适用

Measurement Of RLIP76 Auto Antibodies in Human Serum In Adults With Rheumatologic Diseases.

University of North Texas Health Science Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
100
试验地点
1
主要终点
The focus of the present study is limited to establishing validated protocols for detection of anti-RLIP76 antibodies in human sera.

研究概览

简要总结

It is the investigators aim to determine the feasibility of directly detecting anti-RLIP76 auto-antibodies in human serum using prepared RLIP76 antigen peptides in persons with rheumatologic disease and persons without rheumatologic diesease ("healthy subjects").

详细描述

This is an exploratory study conducted to see the feasibility of measuring the anti-RLIP76 antibody and to standardize the methods for its measurement. We will perform these studies on blood samples obtained from human subjects after informed concent for blood draw for research purposes is obtained by the Clinical Research Co-ordinator (CRC).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (age 18+), non-pregnant subjects with previously diagnosed rheumatologic disease will be candidates for the study.

排除标准

  • Children, pregnant women, prisoner, persons with any medical condition that precludes phlebotomy, and patients unwilling or unable to provide consent.

结局指标

主要结局

The focus of the present study is limited to establishing validated protocols for detection of anti-RLIP76 antibodies in human sera.

时间窗: three years

次要结局

未报告次要终点

研究者

研究点 (1)

Loading locations...

相似试验